Progress toward prevention of cardiovascular disease. A 30-year retrospective

Circulation
|December 1, 1979
PubMed

Insights

The National Heart, Lung, and Blood Institute (NHLBI) drives biomedical research and clinical trials for cardiovascular and pulmonary diseases. Their work has led to advancements reducing mortality from heart attack, hypertension, and stroke.

Area of Science:

  • Biomedical research
  • Cardiovascular and pulmonary diseases
  • Clinical trials

Background:

  • Established in 1948 as the National Heart Institute.
  • Led national research programs for heart, lung, blood, and blood vessel diseases.
  • Increasingly involved in complex clinical trials to validate research findings.

Purpose of the Study:

  • To acquire and evaluate new basic information.
  • To apply research findings to improve disease prevention, detection, and treatment.
  • To sponsor demonstrations and educational activities for healthcare application.

Main Methods:

  • Conducting complex clinical trials.
  • Acquiring and evaluating new biomedical information.
  • Sponsoring demonstrations and educational activities.

Main Results:

  • Development of new equipment like the heart-lung machine and pacemaker.
  • Improvement in diagnostic procedures, operative devices, and treatments.
  • Significant reduction in mortality rates for heart attack, hypertension, and stroke.

Conclusions:

  • NHLBI's comprehensive approach enhances disease prevention and treatment.
  • Technological and medical advancements have drastically reduced cardiovascular and cerebrovascular mortality.
  • Continued research and application of findings are crucial for public health.

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...